Latest news
Pathos Communications hails record July performance - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 07:39:00 GMTUncoded by Premas Life Sciences Marks Two Years of Building India's Genomics Future - Voice of HealthcareVoice of Healthcare · Thu, 06 Aug 2026 07:28:31 GMTPathos AI Secures Up to $2.2 Billion Global Licensing Deal for Alphamab's First-in-Class Bispecific ADC - BioPharma APACBioPharma APAC · Wed, 05 Aug 2026 18:30:31 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity NewsMedCity News · Tue, 04 Aug 2026 20:22:15 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMTPathos AI Secures Global Rights to Alphamab's Experimental Breast Cancer Drug in Up to $1.5 Billion Deal - Voice of HealthcareVoice of Healthcare · Tue, 04 Aug 2026 13:55:12 GMTPathos AI to license experimental breast cancer drug from China's Jiangsu Alphamab Biopharmaceutical - ET PharmaET Pharma · Tue, 04 Aug 2026 11:48:47 GMTPathos AI pads pipeline with $2.2B Alphamab deal, AZ pact - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 11:36:03 GMT